semaglutide and cancer risk Can obesity meds also reduce risk? A retrospective study of 1.1M patients found GLP-1 drugs, especially semaglutide, significantly lower risks for multiple cancers. But not all were equale: liraglutide was linked GLP-1 use linked to better

Two interpretations can coexist without contradiction: Orals are gaining traction

Such commissions come at no additional cost to the consumer and help support the continued publication and syndication of free, research-driven content

Long-term maintenance dosing remains stable for many patients once therapeutic goals are achieved, though periodic reassessment ensures continued appropriateness of therapy

For clinicians, the question isnt just whether GLP1 drugs can reduce alcohol consumption, but how to interpret and discuss this emerging data responsibly

Day 2 Total Macros: 1,490 kcal | Protein: 100 g | Carbs: 138 g | Fat: 48 g 8:00 AM: Breakfast Spinach Egg Toast Macros: 370 kcal | Protein: 20 g | Carbs: 34 g | Fat: 16 g Eggs 2 Whole grain toast 2 slices (70 g) Spinach 40 g Avocado 30 g Prep tip: Toast the bread, cook the eggs, and layer with spinach and avocado

Clinical Importance: Oral semaglutide is the first oral GLP-1 receptor agonist, combining meaningful HbA1c reduction, clinically relevant weight loss, and favorable blood-pressure effects in a once-daily tablet